¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Bone Morphogenetic Protein Receptors, Type II"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • membrane control protein
    ¸·Á¶Àý´Ü¹éÁú
  • olfactory binding protein
    Èİ¢°áÇմܹéÁú
  • oligomeric protein
    ¿Ã¸®°í¸Ó´Ü¹éÁú
  • principal outer membrane protein
    ÁÖ¹Ù±ù¸·´Ü¹éÁú, Áֿܸ·´Ü¹éÁú
  • prosthetic protein
    ¹èÇմܹéÁú
  • protein
    ´Ü¹éÁú
  • protein binding
    ´Ü¹éÁú°áÇÕ
  • protein bound iodine
    ´Ü¹éÁú°áÇÕ¿ä¿Àµå
  • protein granule
    ´Ü¹éÁú°ú¸³
  • protein kinase
    ´Ü¹éÁúŰ³ª¾ÆÁ¦
  • protein kinase C
    ´Ü¹éÁúŰ³ª¾ÆÁ¦C
  • protein layer
    ´Ü¹éÁúÃþ
  • protein p53
    ´Ü¹éÁúp53
  • protein quotient
    ´Ü¹éÁúÁö¼ö
  • protein S
    ´Ü¹éÁúS
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • hypertrophic type
    ºñ´ëÇü
  • tuberculin-type hypersensitivity
    (¢¡delayed-type hypersensitivity) Áö¿¬°ú¹Î
  • introversion type
    ³»ÇâÇü
  • intuitive type
    Á÷°üÇü
  • lepromatous type
    ³ªº´Á¾Çü
  • leptosomatic type
    ¸¶¸¥Çü
  • mating type
    ±³¹èÇü
  • meromyarian type
    ºÎºÐ±ÙÀ°Çü
  • plaque-type mutation
    ÇöóÅ©Çüµ¹¿¬º¯ÀÌ
  • nomenclatural type
    ºÐ·ùÇÐÀû±âÁظí
  • organic reaction type
    ±âÁú¹ÝÀÀÇü
  • ovulatory type
    ¹è¶õÇü
  • parthenogenetic type
    ´Ü¼º»ý½ÄÇü
  • polymyarian type
    ´Ù±ÙÀ°Çü
  • propagative type
    Áõ½ÄÇü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • phased linear array type
    À§»óÂ÷ ¼±Çü ¹è¿­½Ä
  • phased linear array type
    À§»óÂ÷ ¹è¿­½Ä ¼±Çü (êÈßÓó¬ ÛÕÖªãÒ àÊû¡) Æ®·£½ºµà¼­
  • pilus, type 1
    Á¦1Çü ¼¶¸ð
  • plaque-type mutation
    ÇöóÅ©Çü µ¹¿¬º¯ÀÌ
  • platelet-type
    Ç÷¼ÒÆÇÇü(û¡)
  • pneumocyte type i
    È£ÈíÇãÆÄ²Ê¸®¼¼Æ÷
  • pneumocyte type ii
    °ú¸³ÇãÆÄ²Ê¸®¼¼Æ÷
  • precision type attachment
    Á¤¹ÐÇü¾îÅÂÄ¡ ¸ÕÆ®.
  • pyknic body type
    ºñ¸¸Çü ½ÅüÀ¯Çü
  • regular type
    ±ÔÄ¢Çü
  • Irregular bone
    ºÒ±ÔÄ¢Çü
  • Lacrinal bone
    ´«¹°»À´©°ñ
  • Lamellar membranous boneSecondary membranous bone
    ÃþÆÇ¸·»ÀÀÌÂ÷¸·»À
  • accessory bone =extra ossicle
    Á¾ÀÚ°ñ(ðúí­Íé), ºÎ°ñ(ÜùÍé), À׿©°ñ(í¥æ®Íé).
  • air bone gap =AB g.
    ±âµµ°ñµµ(û·Â)Â÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • iodized protein
    ¿äµåÈ­´Ü¹éÁú(¡­Ó±ÛÜòõ).
  • iron binding protein =IBP
    ö°áÇÕ ´Ü¹éÁú.
  • iron porphyrin protein
    öÆ÷¸£ÇǸ°´Ü¹éÁú.
  • iron porphyrin protein
    ö(ôÑ)Æ÷¸£ÇǸ°´Ü¹éÁú(Ó±ÛÜòõ).
  • iron porphyrin protein enzymes
    öÆ÷¸£ÇǸ°´Ü¹éÈ¿¼Ò(¡­Ó±ÛÜý£áÈ).
  • iron-sulfur protein
    ÀüÀÚÀü´Þ ö-À¯È²´Ü¹éÁú
  • liver membrane protein
    °£¸·´Ü¹é
  • liver specific protein
    °£Æ¯À̴ܹé
  • low protein diet
    Àú´Ü¹é½Ä(î¸Ó±ÛÜãÝ).
  • maintenance protein
    À¯Áö´Ü¹éÁú(¡­Ó±ÛÜòõ).
  • major basic protein
    ÁÖ±âÀú´Ü¹é
  • major basic protein
    ÁÖ¿ä ±âÃʴܹé(ñ«é© Ðñõ¨Ó±ÛÜ)
  • matrix protein
    ±âÁú´Ü¹éÁú
  • membrane control protein
    ¸·Á¶Àý´Ü¹é
  • mitogen-activated protein kinase
    ¹ÌÅä°Õ Ȱ¼º ´Ü¹é ±Í³ªÁ¦(¡­ üÀàõ Ó±ÛÜ ¡­ )
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Third metacarpal bone
    ¼Â°¼ÕÇ㸮»À
    [¿¾ ¿ë¾î] Á¦1Áß¼ö°ñ
  • Scaphoid bone
    ¼Õ¹è»À
    [¿¾ ¿ë¾î] ÁÖ»ó°ñ
  • Tubercle of scaphoid bone
    ¼Õ¹è»À°áÀý
    [¿¾ ¿ë¾î] ÁÖ»ó°ñ°áÀý
  • Gelatinous bone marrow
    ¾Æ±³°ñ¼ö [¾Æ±³»À¼ÓÁú]
    [¿¾ ¿ë¾î] ±³¾ç°ñ¼ö
  • Gelatinous bone marrow
    ¾Æ±³°ñ¼ö [¾Æ±³»À¼ÓÁú]
    [¿¾ ¿ë¾î] ¾Æ±³°ñ¼ö
  • Medial cuneiform bone
    ¾ÈÂʽû±â»À
    [¿¾ ¿ë¾î] ³»Ãø¼³»ó°ñ
  • Capitate bone
    ¾Ë¸Ó¸®»À
    [¿¾ ¿ë¾î] À¯µÎ°ñ
  • Perichondral bone
    ¿¬°ñ¸·»À
    [¿¾ ¿ë¾î] ¿¬°ñ¸·°ñ
  • Cartilagenous bone
    ¿¬°ñ»À
    [¿¾ ¿ë¾î] ¿¬°ñ¼º°ñ
  • Definite compact bone
    ¿Ï¼ºÄ¡¹Ð»À
    [¿¾ ¿ë¾î] ¿Ï¼ºÄ¡¹Ð°ñ
  • Frontal bone
    À̸¶»À [ÀüµÎ°ñ]
    [¿¾ ¿ë¾î] ÀüµÎ°ñ
  • Squama of frontal bone
    À̸¶»Àºñ´Ã
    [¿¾ ¿ë¾î] ÀüµÎ¸°
  • Secondary bone
    ÀÌÂ÷»À
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ
  • Secondary bone trabecula
    ÀÌÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¼ÒÁÖ
  • Secondary sponge bone
    ÀÌÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÌÂ÷ÇØ¸é°ñ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cyclic AMP receptor protein
    °í¸®AMP ¼ö¿ëü ´Ü¹éÁú(áôé»ô÷Ó±ÛÜòõ)
  • delipidized protein
    Å»Áö´Ü¹éÁú(÷­ò·Ó±ÛÜòõ)
  • derived protein
    À¯µµ´Ü¹éÁú(ë¯ÓôÓ±ÛÜòõ)
  • DNA binding protein
    DNA °áÇÕ ´Ü¹éÁú(Ì¿ùêÓ±ÛÜòõ) (ÔÒ) single strand binding protein
  • dna G protein
    dna G ´Ü¹éÁú(Ó±ÛÜòõ)
  • DNA-melting protein
    "DNAÀ¶ÇØ ´Ü¹éÁú(ë×ú°Ó±ÛÜòõ), (ÔÒ) single-strand binding protein"
  • DNA unwinding protein
    "DNA Ç®±â ´Ü¹éÁú(Ó±ÛÜòõ), (ÔÒ) single-strand binding protein"
  • docking protein
    µµÅ· ´Ü¹éÁú(Ó±ÛÜòõ)
  • early protein
    Á¶±â ´Ü¹éÁú (ðÄÑ¢Ó±ÛÜòõ)
  • ectopic protein
    ÀÌ¼Ò ´Ü¹éÁú(ì¶á¶Ó±ÛÜòõ)
  • eIF-2 stimulating protein
    eIF-2 ÀÚ±Ø ´Ü¹éÁú(í©Ð½Ó±ÛÜòõ)
  • electron transfer protein
    ÀüÀÚÀü´Þ ´Ü¹éÁú(ï³í­îîÓ¹Ó±ÛÜòõ)
  • encephalitogenic protein
    ³ú¿°»ý¼º ´Ü¹éÁú(Òàæúßæà÷Ó±ÛÜòõ)
  • exocellular protein
    ¼¼Æ÷(á¬øà)¹Û ´Ü¹éÁú(Ó±ÛÜòõ)
  • expressor protein
    ¹ßÇöÀÚ ´Ü¹éÁú (Û¡úÞí­Ó±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
SCP single-celled protein; standard care plan; sodium cellulose phosphate; soluble cytoplasmic protein; ...
TP temperature and pressure; temperature probe; temporal peak; temporoparietal; tension pneumothorax; t...
TSP testis-specific protein; thrombin-sensitive protein; thrombospondin; total serum protein; total susp...
beta [Greek letter beta] an anomer of a carbohydrate; buffer capacity; carbon separated from a carboxyl by one other carbon i...
PRKAR1A protein kinase, cyclic adenosine monophosphate-dependent, regulatory, type 1 alpha
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
KIR Killer cell Immunoglobulin-like Receptors
MBR Mitochondrial benzodiazepine receptors
mAChRs Muscarinic ACh receptors
mAChR Muscarinic cholinergic receptors
PPAR gamma Peroxisome-proliferator-activated receptors gamma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • nonnecrotizing type
    ºñ±«»ç¼º ÇüÅÂ
  • oral-facial-digital syndrome, type I
    IÇü±¸-¾È¸é-ÁöÁõÈıº
    X-¿¬°ü¼º ¿ì¼º À¯Àüº´À¸·Î¼­ ³²ÀÚ¿¡°Ô´Â Ä¡¸íÀûÀ¸·Î ±¼ÁöÁõ, ´ÙÁöÁõ, ÇÕÁöÁõ µîÀÌ Æ¯Â¡À̸ç, µÎ°³, ¾È¸é, ¼³, ±¸°³ ¹× ÇÏ¾Ç ±âÇüÀ» ¼ö¹ÝÇϰųª Áö´É ÀúÇÏ, Å»¸ðÁõ, ¾È¸é Áö·ç¸¦ ¼ö¹ÝÇÑ´Ù.
  • pedunclated type
    À¯°æÇü
  • personality type
    Àμº
  • pontic of root extension type
    À¯±Ù °¡°øÃ¼
    ¼ÒÇüÀÇ Ä¡±ÙÀ» °¡Áö°í ¹ßÄ¡¿Í ¼Ó¿¡ ÀûÇյǴ °¡ °øÃ¼, Ä¡°æºÎ¿Í ÇüÅ ±×¸®°í Ä¡Àº¿¬°úÀÇ °ü°è°¡ ÀÚ¿¬¿¡ °¡±õ°í ½É¹ÌÀûÀÌ°í °¡Àå ¿ì¼öÇϸç, ÀåÂø ÈÄ Ä¡ÀºÀÌ ¾à°£ ÅðÃàÇÏ¿©µµ °¡°øÃ¼¿ÍÀÇ »çÀÌ¿¡ °ø±ØÀÌ »ý±âÁö ¾Ê°í »ç¿ë°¨µµ ¾çÈ£ÇÏ´Ù. ´ë°³ Áï½Ã °¡°ø ÀÇÄ¡·Î¼­ ¹ßÄ¡ Á÷ÈÄ¿¡ ÀåÂøµÈ´Ù.
  • precision type attachment
    Á¤¹ÐÇü ºÎÂø ÀåÄ¡
  • pseudohypertrophic type
    °¡¼º ºñ´ëÇü
  • recurring type
    Àç¹ß¼º
  • repository type of penicillin
    ÀúÀåÇü Æä´Ï½Ç¸°
  • salivary gland type
    Ÿ¾×¼± À¯Çü
  • schizoaffetive type
    ºÐ¿­ Á¤µ¿Çü, ºÐ¿­ Á¤°¨Çü
  • schizoid type
    ºÐ¿­Çü
  • schizophrenia of childhood type
    ¾Æµ¿Çü Á¤½Å ºÐ¿­Áõ
    »çÃá±â¿¡ ¹ßº´ÇÏ´Â Á¤½Å ºÐ¿­ÁõÀ¸·Î¼­ ÀÚÆó¼º, ³»Ç⼺, ºñÁ¤ÇüÀû ÇൿÀ» Ư¡À¸·Î ÇÑ´Ù.
  • screen-type cassette
    ½ºÅ©¸°Çü Ä«¼¼Æ®
    ´ë°Ô ±Ý¼ÓÀ¸·Î ¸¸µé¾î Á³À¸¸ç, ³ëÃâ¸éÀº º£ÀÌŬ¶óÀÌÆ®, ¾Ë·ç¹Ì´½, ¸¶±×³×½·°ú °°Àº ³·Àº ¿øÀÚ ¹øÈ£ÀÇ ¹°Áú·Î µÇ¾î ÀÖ°í, Áõ°¨Áö¸¦ Æ÷ÇÔÇϰí À־ ±× »çÀÌ¿¡ X-¼± ³ëÃâÀ» À§ÇÑ "½ºÅ©¸°Çü" Çʸ§À» À§Ä¡½ÃŲ´Ù.
  • spaced type of deciduous dentition
    À¯±ØÇü À¯Ä¡¿­±Ã
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
receptors, gastrointestinal hormone Cell surface proteins that bind gastrointestinal hormones with high affinity and trigger intracellular changes influencing the behaviour of cells. most gastrointestinal hormones also act as neurotransmitters so these receptors are also present in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, glucagon Cell surface receptors that bind glucagon with high affinity and trigger intracellular changes which influence the behaviour of cells. Activation of glucagon receptors causes a variety of effects; the best understood is the initiation of a complex enzymatic cascade in the liver which ultimately increases the availability of glucose to body organs.
(12 Dec 1998)
receptors, glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example.
(12 Dec 1998)
receptors, glutamate Cell-surface proteins that bind glutamate and trigger changes which influence the behaviour of cells. Glutamate receptors include ionotropic receptors (ampa, kainate, and n-methyl-d-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.
(12 Dec 1998)
receptors, glycine Cell surface receptors that bind glycine with high affinity and trigger intracellular changes which influence the behaviour of cells. Glycine receptors in the central nervous system have an intrinsic chloride channel and are usually inhibitory.
(12 Dec 1998)
receptors, gonadotropin Those protein complexes or molecular sites on the surfaces of gonadal and other sensitive cells that bind gonadotropins and thereby modify the functions of those cells; hcg, lh, and fsh are the major specific gonadotropins.
(12 Dec 1998)
receptors, granulocyte-colony-stimulating factor Receptors that bind and internalise granulocyte-colony-stimulating factor. Their mw is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells.
(12 Dec 1998)
receptors, granulocyte-macrophage colony-stimulating factor Receptors that bind and internalise the granulocyte-macrophage stimulating factor. Their mw is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor.
(12 Dec 1998)
receptors, growth factor Cell surface receptors that bind growth or trophic factors with high affinity, triggering intracellular responses which influence the growth, differentiation, or survival of cells.
(12 Dec 1998)
receptors, histamine Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behaviour of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognised and designated h1, h2, and h3. They differ in pharmacology, distribution, and mode of action.
(12 Dec 1998)
receptors, histamine h1 A class of histamine receptors discriminated by their pharmacology and mode of action. most histamine h1 receptors operate through the inositol phosphate/diacylglycerol second messenger system. Among the many responses mediated by these receptors are smooth muscle contraction, increased vascular permeability, hormone release, and cerebral glyconeogenesis.
(12 Dec 1998)
receptors, histamine h2 A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine h2 receptors act via g-proteins to stimulate adenylate cylase. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function.
(12 Dec 1998)
receptors, histamine h3 A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine h3 receptors were first recognised as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, HIV Cellular receptors that bind the human immunodeficiency virus that causes aids. Included are CD4 antigens, found on t4 lymphocytes, and monocytes/macrophages, which bind to the HIV envelope protein gp120.
(12 Dec 1998)
receptors, IgE Specific molecular sites on the surface of b- and T-lymphocytes which combine with iges. Two subclasses exist: low affinity receptors (fc epsilon ri) and high affinity receptors (fc epsilon rii).
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á